Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tasker

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Phosphoinositide-3-kinase inhibitors: evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511Brian A Lanman, Anthony B Reed, Victor J Cee, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2011
Quinolinone-based agonists of S1P₁: use of a N-scan SAR strategy to optimize in vitro and in vivo activityLewis D Pennington, Michael D Croghan, Kelvin K C Sham, et al.
Journal of Medicinal Chemistry|September 10, 1999
Second-generation peptidomimetic inhibitors of protein farnesyltransferase demonstrating improved cellular potency and significant in vivo efficacyS J O'Connor, K J Barr, L Wang, et al.
Journal of Medicinal Chemistry|September 27, 2008
Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffoldBrad Herberich, Guo-Qiang Cao, Partha P Chakrabarti, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2016
Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitorsRyan P Wurz, Christine Sastri, Derin C D'Amico, et al.
Journal of Medicinal Chemistry|September 4, 2008
Design, synthesis, and biological evaluation of potent c-Met inhibitorsNoel D D'Angelo, Steven F Bellon, Shon K Booker, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2015
The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitorsRyan P Wurz, Liping H Pettus, Claire Jackson, et al.
Journal of Medicinal Chemistry|December 1, 2001
New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor modelsB G Szczepankiewicz, G Liu, H S Jae, et al.
ACS Medicinal Chemistry Letters|April 21, 2016
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase InhibitorsVictor J Cee, Frank Chavez, Bradley Herberich, et al.
Journal of Medicinal Chemistry|June 11, 2016
Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase InhibitorsLiping H Pettus, Kristin L Andrews, Shon K Booker, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Phosphoinositide-3-kinase inhibitors: evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511Brian A Lanman, Anthony B Reed, Victor J Cee, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2011
Quinolinone-based agonists of S1P₁: use of a N-scan SAR strategy to optimize in vitro and in vivo activityLewis D Pennington, Michael D Croghan, Kelvin K C Sham, et al.
Journal of Medicinal Chemistry|September 10, 1999
Second-generation peptidomimetic inhibitors of protein farnesyltransferase demonstrating improved cellular potency and significant in vivo efficacyS J O'Connor, K J Barr, L Wang, et al.
Journal of Medicinal Chemistry|September 27, 2008
Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffoldBrad Herberich, Guo-Qiang Cao, Partha P Chakrabarti, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2016
Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitorsRyan P Wurz, Christine Sastri, Derin C D'Amico, et al.
Journal of Medicinal Chemistry|September 4, 2008
Design, synthesis, and biological evaluation of potent c-Met inhibitorsNoel D D'Angelo, Steven F Bellon, Shon K Booker, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2015
The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitorsRyan P Wurz, Liping H Pettus, Claire Jackson, et al.
Journal of Medicinal Chemistry|December 1, 2001
New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor modelsB G Szczepankiewicz, G Liu, H S Jae, et al.
ACS Medicinal Chemistry Letters|April 21, 2016
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase InhibitorsVictor J Cee, Frank Chavez, Bradley Herberich, et al.
Journal of Medicinal Chemistry|June 11, 2016
Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase InhibitorsLiping H Pettus, Kristin L Andrews, Shon K Booker, et al.
Pageof 10